BEN-MAIMON CAROLE
SEC insider (Form 3/4/5 filer). CIK 0001529611. President and CEO at Larimar Therapeutics, Inc. (LRMR). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 26, 2026. Located in BALA CYNWYD, PA.
Companies BEN-MAIMON CAROLE has filed insider reports for
- Larimar Therapeutics, Inc. (LRMR): Director, Officer, President and CEO
BEN-MAIMON CAROLE
CIK: 0001529611
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LRMR
Larimar Therapeutics, Inc.
DirectorOfficer